ArticleCardiovascular diabetology2013

Co-morbidity but not dysglycaemia reduces quality of life in patients with type-2 diabetes treated with oral mono- or dual combination therapy--an analysis of the DiaRegis registry.

Jürgen Wasem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.